Otros artículos de Luisa María Botella
Botella LM, T Sánchez-Elsner, C Rius, A Corbí, and Bernabeu C. Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation. J Biol Chem. 276:34486-34494 (2001).Sánchez-Elsner T, Botella LM, Velasco B, Corbí A, Attisano L, Bernabéu C. Synergistic Cooperation between Hypoxia and Transforming Growth Factor-beta Pathways on Human Vascular Endothelial Growth Factor Gene Expression.J Biol Chem 276:38527-38535 (2001)Botella LM, Sánchez-Elsner T, Kojima S, Shimada J, Guerrero-Esteo M, Sanz-Rodriguez F, Ratziu V, Langa C, Ramírez JR , Friedman SL and Bernabeu C. Synergistic transcriptional activation of endoglin and TGF-ß signaling components by Sp1 and KLF6, and their potential role in the response to vascular injury. Blood 100: 4001-4010. (2002).Sánchez-Elsner T, Botella LM, Velasco B, Langa C, and C Bernabéu. Endoglin expression is regulated by a transcriptional cooperation between hypoxia and transforming growth factor-ß pathways. J. Biol. Chem. 277:43799-43808 (2002).Cabello G, Galaz S, Botella LM, Calaf G, Pacheco M, Stockert JC, Villanueva A,Canete M, Juarranz A. The pesticide malathion induces alterations in actin cytoskeleton and in cell adhesion of cultured breast carcinoma cells. Int J Oncol. 23:697-704. (2003).Sánchez-Elsner T, Sanz-Rodriguez, F, Varela E, Ramírez J R, Bernabéu C and Botella LM. A cross-talk between hypoxia and TGF-ß orchestrates erythropoietin gene regulation through Sp1 and Smads. J. Mol. Biol. 336:9-24(2004).Botella LM, Sanz-Rodriguez F, Sanchez-Elsner T., Langa C, Vary C, Roughley P, Ramirez JR, and Bernabeu C. Lumican is downregulated in cells expressing endoglin. Matrix Biology 22:561-572 (2004).Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM, Banville D., Vary C and Bernabeu C. Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the LIM family of proteins. J. Biol. Chem. 279:32858-32868 (2004).Perez-Molino A, Zarrabeitia R, Fernandez A, Botella LM. Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis. Med Clin (Barc). 123:118-119. (2004).Sanz-Rodriguez F, Fernandez-L. A., Zarrabeitia R. Perez-Molino A., Ramírez J.R., Coto E., Bernabeu C and Botella LM. Deficient Endoglin Upregulation In Activated Monocytes from Hereditary Hemorrhagic Telangiectasia Patients. Clin. Chem. 50:2003-2011 (2004).
Para comunicarse con Luisa María Botella mencionar a SIIC como
referencia:
cibluisa@cib.csic.es
Autora invitada
7 de diciembre, 2004
Descripción aprobada
21 de febrero, 2005
Reedición siicsalud
7 de junio, 2021